Factor IX Denver, ASN 346-->ASP mutation resulting in a dysfunctional protein with defective factor VIIIa interaction

Thromb Haemost. 2001 Sep;86(3):862-70.

Abstract

Hemophilia B is a sex-linked recessive bleeding disorder characterized by the presence of either a decreased amount of normal factor IX (FIX) or the presence of a dysfunctional FIX. We have identified a unique mutation in a family with mild hemophilia B. DNA analysis of family members revealed a single base transition in the 8th exon of the FIX gene predicting an amino acid change of Asn 346-->Asp in the catalytic domain. The FIX variant, named FIX Denver, was purified from proband plasma. Kinetic studies of factor X (FX) interactions with normal FIXa or FIXa Denver and phospholipid (PL) showed little difference in kcat but a significant difference when factor VIIIa (FVIIIa) was included in the reaction. Using kinetic assays to infer the Kd of FIXa for FVIIIa, normal FIXa had a Kd of 0.095 nM while that of FIXa Denver was 9.85 nM. The major defect caused by this point mutation is a marked decrease in the affinity of FIXa Denver for factor VIIIa.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Amino Acid Substitution*
  • Blood Coagulation Tests
  • Cysteine Endopeptidases / metabolism
  • DNA Mutational Analysis
  • Factor IX / genetics*
  • Factor IX / isolation & purification
  • Factor VIIIa / metabolism
  • Factor X / metabolism
  • Hemophilia B / genetics*
  • Hemorrhage / etiology
  • Humans
  • Kinetics
  • Liposomes / pharmacology
  • Male
  • Mutation, Missense*
  • Neoplasm Proteins*
  • Phosphatidylcholines / pharmacology
  • Phosphatidylserines / pharmacology
  • Point Mutation*
  • Thromboplastin / metabolism

Substances

  • Liposomes
  • Neoplasm Proteins
  • Phosphatidylcholines
  • Phosphatidylserines
  • factor IX Denver
  • Factor VIIIa
  • Factor IX
  • Factor X
  • Thromboplastin
  • Cysteine Endopeptidases
  • cancer procoagulant